ACTC Lab presents abstracts at AACR Annual Meeting 2019

29 March-3 April 2019, Atlanta, Georgia, USA

A number of ACTC Lab members are presenting abstracts at the 109th American Association for Cancer Research (AACR) Annual Meeting in Atlanta, Georgia.

All abstracts include the development of highly specific and sensitive liquid biopsy approaches for the detection of genetic alterations on Circulating Tumor Cells (CTCs) and exosomes.

Monday, April 1, from 1:00 p.m. to 4:00 p.m.

Poster session # PO.CL11.11: Circulating and Cell-free Biomarkers for Diagnosis and Monitoring of Cancer 3

#2237
Detection of CK-19 mRNA positive CTCs, isolated with a size-based microfluidics platform, in NSCLC patients under osimertinib therapy
Aliki Ntzifa, Athanasios Kotsakis, Vassilis Georgoulias, Evi Lianidou

#2241
Molecular characterization of circulating tumor cells in head and neck squamous cell carcinoma: Direct comparison of a label-independent size-based microfluidic device with EpCAM-based CTC enrichment
Martha Zavridou, Sophia Mastoraki, Areti D. Strati, George Koutsodontis, Apostolos Klinakis, Amanda Psyrri, Evi S. Lianidou

#2290
Expression pattern of androgen receptor (AR), splice variant 7 (AR-V7) and splice variant 567 (AR-567) in circulating tumor cells and paired plasma-derived exosomes in metastatic castration resistant prostate cancer
Areti D. Strati, Martha Zavridou, Evangelos Bournakis, Sophia Mastoraki, Evi S. Lianidou

---